Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S. approval Wednesday of a novel drug from Amgen Inc.
A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.
The United States Food and Drug Administration is warning consumers to avoid dietary supplements sold by a Las Vegas company because they may contain anabolic steroids that can cause liver damage.
Australian Prime Minister Tony Abbott said Sunday his nation will adopt a "no jab, no pay" policy to block parents who refuse to vaccinate their children from accessing some government welfare.
Once banned because it is a close cousin to marijuana, hemp is coming back in the state of Colorado and now has its own convention, attracting international interest as a new crop for farmers struggling to find new crops to stay afloat.
The U.S. and Liberian governments have just begun the first formal patient testing of an experimental Ebola virus treatment that's only been used on an emergency basis.
A new vaccine against sexually transmitted human papillomavirus is more effective than the previous version and may protect against 90 percent of all cervical cancers worldwide, researchers said Wednesday.
Floral nectar contains a bouquet of natural chemicals that may help fight parasite infection in bumble bees, a study said Wednesday.
U.S. President Barack Obama on Tuesday called for the United States to lead the way toward a "new era of medicine" by boosting funds for modern medical research.
The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe.